Atlas Trials

A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue Sarcoma

Clinical trial NCT04900766 · TERMINATED

Trial details

NCT number
NCT04900766
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Unresectable or Metastatic Bone and Soft Tissue Sarcoma
Start date
2021-08-11
Primary completion
2023-02-03
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.